XTL BIOPHARMACEUTICALS LTD - XTLB

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q3 2026 · Compare: Q2 2026
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
CITADEL ADVISORS LLC History New 42,531 102 0.0% — 1 +42,531 New Q3 2026 Nov 16, 2026
RHUMBLINE ADVISERS History Added to 6,871 16 0.0% 0.0% 2 +643 10.32% Q3 2026 Nov 10, 2026
GAMMA Investing LLC History Added to 3,436 7 0.0% 0.0% 3 +2,223 183.26% Q3 2026 Oct 08, 2026
UBS Group AG History Added to 427 0 — — — +302 241.6% Q3 2026 Nov 10, 2026
ROYAL BANK OF CANADA History New 100 0 — — — +100 New Q3 2026 Nov 16, 2026